ENVISION: A phase 3b/4 randomized, double‐blind, placebo‐controlled, parallel‐group study to verify the clinical benefit of aducanumab in participants with early Alzheimer’s disease

Authors :: Jennifer Murphy
Paul Aisen
Frederik Barkhof
Carmen Castrillo‐Viguera
Wenting Cheng
Sharon Cohen
Oskar Hansson
Ping He
Takeshi Iwatsubo
Judy Jaeger
Philip H. Montenigro
Carrie E. Rubel
Catherine J. Mummery
John O'Gorman
Annie M Racine
Bruno Vellas
Shuang Wu
Samantha Budd Haeberlein
Source :: Alzheimer's & Dementia. 18
Publication Year :: 2022
Publisher :: Wiley, 2022.

Subjects :: Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Epidemiology
Health Policy
Neurology (clinical)
Geriatrics and Gerontology

Tools